Article Text

PDF
“Worm in the eye”: the rationale for treatment of DUSN in south India
  1. K Myint1,
  2. R Sahay2,
  3. S Mon1,
  4. V R Saravanan2,
  5. V Narendran2,
  6. B Dhillon1
  1. 1Eye Pavilion, Royal Infirmary of Edinburgh, Edinburgh, UK
  2. 2Aravind Eye Hospital, Coimbatore, India
  1. Correspondence to: Dr Kyaw Myint Princess Alexandra Eye Pavilion, Chalmers Street, Edinburgh EH3 9HA, UK; kmyintuk{at}yahoo.co.uk

Abstract

Aim: To discuss the rationale for different techniques of treatment for DUSN (diffuse unilateral subacute neuroretinitis) and their effectiveness in two patients from south India.

Methods: Two rare cases of live worms in DUSN from India are reported, where filarial Brugia malayi is endemic. Both cases presented with progressive unilateral loss of vision with no history of animal contact. They were 40 year old, apparently healthy men. In case 1, the worm (1500–2000 μm) was easy to identify with wriggling movements among crisscrossing diffuse subretinal tracks. The worm was destroyed by a single shot of laser to its advancing end, which was followed by oral steroid to control the inflammation caused by the dead worm. In case 2, the worm was small and difficult to identify. Initially diffuse neuroretinitis was diagnosed and treated with intravenous methylprednisolone and oral corticosteroid. A week later, a small live worm (400–600 µm) was found and subsequently destroyed by laser photocoagulation followed by a combination of anthelminthics.

Results: The patients’ vision had improved to 6/60–6/36 from counting fingers after a few weeks.

Conclusion: The role of a combination of laser treatment, systemic steroid, and anthelminthics is discussed.

  • DUSN, diffuse unilateral subacute neuroretinitis
  • RAPD, relative afferent pupillary defect
  • VA, visual acuity
  • Brugia malayi
  • diffuse unilateral subacute neuroretinitis
  • DUSN, diffuse unilateral subacute neuroretinitis
  • RAPD, relative afferent pupillary defect
  • VA, visual acuity
  • Brugia malayi
  • diffuse unilateral subacute neuroretinitis

Statistics from Altmetric.com

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.